1 Min Read
Feb 14 (Reuters) - Axsome Therapeutics Inc :
* Axsome Therapeutics receives FDA fast track designation for AXS-05 for treatment resistant depression Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.